[1]
Fuca, G., Verzoni, E., Mennitto, A., Prisciandaro, M., Ratta, R. and Procopio, G. 2017. Real-world safety profile of abiraterone acetate in patients with castration-resistant prostate cancer and cardiovascular comorbidities: a retrospective, single center study:  . Cancer Breaking News. 5, 3 (Dec. 2017), 20–24. DOI:https://doi.org/10.19156/cbn.2017.0055.